Advertisement

Benign Diseases of the Ovary

  • David Suster
  • Martina Z. Liu
  • Douglas I. LinEmail author
Chapter

Abstract

In surgical pathology, an understanding of the normal ovarian anatomy and the range of nonneoplastic lesions of the ovary is essential during the examination of gynecological specimens. Pathologists routinely evaluate nonneoplastic adult ovaries as components of (1) hysterectomy procedures for uterine leiomyomata, uterine prolapse, vaginal bleeding, or gynecological cancer and (2) risk-reducing prophylactic salpingo-oophorectomy, with the primary goals of excluding ovarian malignancy and/or determining whether the ovary is the source of hormone production driving uterine cancer. In these scenarios, with the exception of endometriosis, ovarian infection, or a hormone-producing lesion, any incidental nonneoplastic lesion encountered in the ovary is likely not of clinical significance. However, another frequently encountered scenario is examination of the ovary via biopsy, cystectomy, or excision for a specific purpose, including ovarian enlargement, cyst formation, masses, torsion, infection, infertility, or ectopic pregnancy, in which the ovary is submitted for evaluation for a clinical or radiological reason. Each of these settings requires the pathologist to have knowledge of the normal ovarian anatomy, the histology, and the range of nonneoplastic lesions of the ovary in order to guide the obstetrician-gynecologist or gynecologic oncologist to the appropriate treatment and follow-up.

Keywords

Ovary Benign Nonneoplastic Anatomy Histology 

References

  1. 1.
    Boss JH, Scully RE, Wegner KH, Cohen RB. Structural Variations in the adult ovary. Clinical significance. Obstet Gynecol. 1965;25:747–64.PubMedGoogle Scholar
  2. 2.
    Tong G-X, Hamele-Bena D. The differential expression of PAX2 and PAX8 in the ovarian surface epithelium and fallopian tubal epithelium is an important issue. Am J Surg Pathol. 2012;36:1099–100.PubMedCrossRefGoogle Scholar
  3. 3.
    Ozcan A, Liles N, Coffey D, Shen SS, Truong LD. PAX2 and PAX8 expression in primary and metastatic Müllerian epithelial Tumors. Am J Surg Pathol. 2011;35:1837–47.PubMedCrossRefGoogle Scholar
  4. 4.
    Judd HL, Lucas WE, Yen SS. Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer. Am J Obstet Gynecol. 1974;118:793–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Lucisano A, Russo N, Acampora MG, Fabiano A, Fattibene M, Parlati E, Maniccia E, Dell’Acqua S. Ovarian and peripheral androgen and oestrogen levels in post-menopausal women: correlations with ovarian histology. Maturitas. 1986;8:57–65.PubMedCrossRefGoogle Scholar
  6. 6.
    Carrasco-Juan JL, Álvarez-Argüelles Cabrera H, Martín Corriente MC, González-Gómez M, Valladares Parrilla R, Gutiérrez García R, Díaz-Flores L. Ovarian Leydig cells (OLC): a histomorphological and immunohistochemical study. Histol Histopathol. 2017;32:1089–97.PubMedGoogle Scholar
  7. 7.
    Sternberg WH. The morphology, androgenic function, hyperplasia, and tumors of the human ovarian hilus cells. Am J Pathol. 1949;25:493–521.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Russo L, Woolmough E, Heatley MK. Structural and cell surface antigen expression in the rete ovarii and epoophoron differs from that in the Fallopian tube and in endometriosis. Histopathology. 2000;37:64–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Goyal A, Masand RP, Roma AA. Value of PAX-8 and SF-1 immunohistochemistry in the distinction between female adnexal tumor of probable Wolffian origin and its mimics. Int J Gynecol Pathol. 2016;35:167–75.PubMedCrossRefGoogle Scholar
  10. 10.
    Kaipia A, Hsueh AJ. Regulation of ovarian follicle atresia. Annu Rev Physiol. 1997;59:349–63.PubMedCrossRefPubMedCentralGoogle Scholar
  11. 11.
    Quirk SM, Cowan RG, Harman RM, Hu C-L, Porter DA. Ovarian follicular growth and atresia: the relationship between cell proliferation and survival. J Anim Sci. 2004;82(E-Suppl):E40–52.PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Clarke-Pearson DL. Screening for ovarian cancer. N Engl J Med. 2009;361:170–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Ferenczy A, Bergeron C. Histology of the human endometrium: from birth to senescence. Ann N Y Acad Sci. 1991;622:6–27.PubMedCrossRefGoogle Scholar
  14. 14.
    Walton KL, Makanji Y, Robertson DM, Harrison CA. The synthesis and secretion of inhibins. Vitam Horm. 2011;85:149–84.PubMedCrossRefGoogle Scholar
  15. 15.
    Dos Reis FM, De Rezende CP. Clinical usefulness of inhibin assays in gynecology and obstetrics. Rev Bras Ginecol Obstet. 2009;31:621–5.PubMedGoogle Scholar
  16. 16.
    Kwok R, Johnson NP. Ovarian biopsy has no role as a routine diagnostic test of ovarian reserve: a systematic review. Reprod Biomed Online. 2012;24:492–5.PubMedCrossRefGoogle Scholar
  17. 17.
    Steiner A. Biomarkers of ovarian reserve as predictors of reproductive potential. Semin Reprod Med. 2013;31:437–42.PubMedCrossRefGoogle Scholar
  18. 18.
    Dumont A, Robin G, Catteau-Jonard S, Dewailly D. Role of anti-Müllerian hormone in pathophysiology, diagnosis and treatment of polycystic ovary syndrome: a review. Reprod Biol Endocrinol. 2015;13:137.PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Dewailly D, Andersen CY, Balen A, et al. The physiology and clinical utility of anti-Müllerian hormone in women. Hum Reprod Update. 2014;20:370–85.PubMedCrossRefGoogle Scholar
  20. 20.
    Nelson WW, Greene RR. Some observations on the histology of the human ovary during pregnancy. Am J Obstet Gynecol. 1958;76:66–90.PubMedCrossRefGoogle Scholar
  21. 21.
    Burandt E, Young RH. Pregnancy luteoma: a study of 20 cases on the occasion of the 50th anniversary of its description by Dr. William H. Sternberg, with an emphasis on the common presence of follicle-like spaces and their diagnostic implications. Am J Surg Pathol. 2014;38:239–44.PubMedCrossRefGoogle Scholar
  22. 22.
    Norris HJ, Taylor HB. Nodular theca-lutein hyperplasia of pregnancy (so-called “pregnancy luteoma”). A clinical and pathologic study of 15 cases. Am J Clin Pathol. 1967;47:557–66.PubMedCrossRefGoogle Scholar
  23. 23.
    Garcia-Bunuel R, Berek JS, Woodruff JD. Luteomas of pregnancy. Obstet Gynecol. 1975;45:407–14.PubMedGoogle Scholar
  24. 24.
    Choi JR, Levine D, Finberg H. Luteoma of pregnancy: sonographic findings in two cases. J Ultrasound Med. 2000;19:877–81.PubMedCrossRefGoogle Scholar
  25. 25.
    Joshi R, Dunaif A. Ovarian disorders of pregnancy. Endocrinol Metab Clin N Am. 1995;24:153–69.CrossRefGoogle Scholar
  26. 26.
    Malinowski AK, Sen J, Sermer M. Hyperreactio luteinalis: maternal and fetal effects. J Obstet Gynaecol Can. 2015;37:715–23.PubMedCrossRefGoogle Scholar
  27. 27.
    Cavoretto P, Giorgione V, Sigismondi C, Mangili G, Serafini A, Dallagiovanna C, Candiani M. Hyperreactio luteinalis: timely diagnosis minimizes the risk of oophorectomy and alerts clinicians to the associated risk of placental insufficiency. Eur J Obstet Gynecol Reprod Biol. 2014;176:10–6.PubMedCrossRefPubMedCentralGoogle Scholar
  28. 28.
    Clement PB, Scully RE. Large solitary luteinized follicle cyst of pregnancy and puerperium: a clinicopathological analysis of eight cases. Am J Surg Pathol. 1980;4:431–8.PubMedCrossRefGoogle Scholar
  29. 29.
    Lomme M, Kostadinov S, Zhang C. Large solitary luteinized follicle cyst of pregnancy and puerperium: report of two cases. Diagn Pathol. 2011;6:3.PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Fang YMV, Gomes J, Lysikiewicz A, Maulik D. Massive luteinized follicular cyst of pregnancy. Obstet Gynecol. 2005;105:1218–21.PubMedCrossRefGoogle Scholar
  31. 31.
    Shi J, Whyte WA, Zepeda-Mendoza CJ, et al. Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation. Genes Dev. 2013;27:2648–62.PubMedPubMedCentralCrossRefGoogle Scholar
  32. 32.
    Herr JC, Heidger PM, Scott JR, Anderson JW, Curet LB, Mossman HW. Decidual cells in the human ovary at term. I. Incidence, gross anatomy and ultrastructural features of merocrine secretion. Am J Anat. 1978;152:7–27.PubMedCrossRefGoogle Scholar
  33. 33.
    Ober WB, Grady HG, Schoenbucher AK. Ectopic ovarian decidua without pregnancy. Am J Pathol. 33:199–217.Google Scholar
  34. 34.
    Suster S, Moran CA. Deciduosis of the appendix. Am J Gastroenterol. 1990;85:841–5.PubMedGoogle Scholar
  35. 35.
    Clement PB. Tumor-like lesions of the ovary associated with pregnancy. Int J Gynecol Pathol. 1993;12:108–15.PubMedCrossRefGoogle Scholar
  36. 36.
    Kondi-Pafiti A, Grapsa D, Kontogianni-Katsarou K, Papadias K, Kairi-Vassilatou E. Ectopic decidua mimicking metastatic lesions--report of three cases and review of the literature. Eur J Gynaecol Oncol. 2005;26:459–61.PubMedGoogle Scholar
  37. 37.
    Clement PB, Young RH, Scully RE. Ovarian granulosa cell proliferations of pregnancy: a report of nine cases. Hum Pathol. 1988;19:657–62.PubMedCrossRefGoogle Scholar
  38. 38.
    Satyanarayana S, Bohre JK. Ovarian granulosa cell “tumorlet” and mature follicles with ectopic decidua in pregnancy—a case report. Indian J Pathol Microbiol. 2001;44:149–50.PubMedGoogle Scholar
  39. 39.
    Bouyer J, Coste J, Fernandez H, Pouly JL, Job-Spira N. Sites of ectopic pregnancy: a 10 year population-based study of 1800 cases. Hum Reprod. 2002;17:3224–30.PubMedCrossRefGoogle Scholar
  40. 40.
    Scutiero G, Di Gioia P, Spada A, Greco P. Primary ovarian pregnancy and its management. J Soc Laparoendosc Surg. 2012;16:492–4.CrossRefGoogle Scholar
  41. 41.
    Herbertsson G, Magnusson SS, Benediktsdottir K. Ovarian pregnancy and IUCD use in a defined complete population. Acta Obstet Gynecol Scand. 1987;66:607–10.PubMedCrossRefGoogle Scholar
  42. 42.
    Raziel A, Golan A, Pansky M, Ron-El R, Bukovsky I, Caspi E. Ovarian pregnancy: a report of twenty cases in one institution. Am J Obstet Gynecol. 1990;163:1182–5.PubMedCrossRefGoogle Scholar
  43. 43.
    Wang Y, Chen H, Zhao M, Fadare O, Zheng W. Primary ovarian pregnancy. Int J Gynecol Pathol. 2018;  https://doi.org/10.1097/PGP.0000000000000482.PubMedCrossRefGoogle Scholar
  44. 44.
    Nippita TA, Baber RJ. Premature ovarian failure: a review. Climacteric. 2007;10:11–22.PubMedCrossRefGoogle Scholar
  45. 45.
    Sun W, Stegmann BJ, Henne M, Catherino WH, Segars JH. A new approach to ovarian reserve testing. Fertil Steril. 2008;90:2196–202.PubMedPubMedCentralCrossRefGoogle Scholar
  46. 46.
    Massin N, Gougeon A, Meduri G, et al. Significance of ovarian histology in the management of patients presenting a premature ovarian failure. Hum Reprod. 2004;19:2555–60.PubMedCrossRefGoogle Scholar
  47. 47.
    Silva CA, Yamakami LYS, Aikawa NE, Araujo DB, Carvalho JF, Bonfá E. Autoimmune primary ovarian insufficiency. Autoimmun Rev. 2014;13:427–30.PubMedCrossRefGoogle Scholar
  48. 48.
    Welt CK, Falorni A, Taylor AE, Martin KA, Hall JE. Selective theca cell dysfunction in autoimmune oophoritis results in multifollicular development, decreased estradiol, and elevated inhibin B levels. J Clin Endocrinol Metab. 2005;90:3069–76.PubMedCrossRefGoogle Scholar
  49. 49.
    La Marca A, Brozzetti A, Sighinolfi G, Marzotti S, Volpe A, Falorni A. Primary ovarian insufficiency: autoimmune causes. Curr Opin Obstet Gynecol. 2010;22:1.CrossRefGoogle Scholar
  50. 50.
    Bannatyne P, Russell P, Shearman RP. Autoimmune oophoritis: a clinicopathologic assessment of 12 cases. Int J Gynecol Pathol. 1990;9:191–207.PubMedCrossRefPubMedCentralGoogle Scholar
  51. 51.
    Sedmak DD, Hart WR, Tubbs RR. Autoimmune oophoritis: a histopathologic study of involved ovaries with immunologic characterization of the mononuclear cell infiltrate. Int J Gynecol Pathol. 1987;6:73–81.PubMedCrossRefPubMedCentralGoogle Scholar
  52. 52.
    Lewis J. Eosinophilic perifolliculitis: a variant of autoimmune oophoritis? Int J Gynecol Pathol. 1993;12:360–4.PubMedCrossRefPubMedCentralGoogle Scholar
  53. 53.
    Aittomäki K, Lucena JL, Pakarinen P, et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell. 1995;82:959–68.PubMedCrossRefPubMedCentralGoogle Scholar
  54. 54.
    Lourenço D, Brauner R, Lin L, et al. Mutations in NR5A1 associated with ovarian insufficiency. N Engl J Med. 2009;360:1200–10.PubMedPubMedCentralCrossRefGoogle Scholar
  55. 55.
    Levine MA, Downs RW, Moses AM, Breslau NA, Marx SJ, Lasker RD, Rizzoli RE, Aurbach GD, Spiegel AM. Resistance to multiple hormones in patients with pseudohypoparathyroidism. Association with deficient activity of guanine nucleotide regulatory protein. Am J Med. 1983;74:545–56.PubMedCrossRefGoogle Scholar
  56. 56.
    Aittomäki K, Herva R, Stenman UH, Juntunen K, Ylöstalo P, Hovatta O, de la Chapelle A. Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene. J Clin Endocrinol Metab. 1996;81:3722–6.Google Scholar
  57. 57.
    Rogenhofer N, Pavlik R, Jeschke U, Wypior G, Ochsenkühn R, Thaler CJ. Effective ovarian stimulation in a patient with resistant ovary syndrome and antigonadotrophin antibodies. Am J Reprod Immunol. 2015;73:185–91.PubMedCrossRefGoogle Scholar
  58. 58.
    Koninckx PR, Brosens IA. The “gonadotropin-resistant ovary” syndrome as a cause of secondary amenorrhea and infertility. Fertil Steril. 1977;28:926–31.PubMedCrossRefGoogle Scholar
  59. 59.
    Russell P, Bannatyne P, Shearman RP, Fraser IS, Corbett P. Premature hypergonadotropic ovarian failure: clinicopathological study of 19 cases. Int J Gynecol Pathol. 1982;1:185–201.PubMedCrossRefGoogle Scholar
  60. 60.
    Sheehan MT. Polycystic ovarian syndrome: diagnosis and management. Clin Med Res. 2004;2:13–27.PubMedPubMedCentralCrossRefGoogle Scholar
  61. 61.
    Strauss JF. Some new thoughts on the pathophysiology and genetics of polycystic ovary syndrome. Ann N Y Acad Sci. 2003;997:42–8.PubMedCrossRefPubMedCentralGoogle Scholar
  62. 62.
    Varanasi LC, Subasinghe A, Jayasinghe YL, Callegari ET, Garland SM, Gorelik A, Wark JD. Polycystic ovarian syndrome: prevalence and impact on the wellbeing of Australian women aged 16-29 years. Aust New Zeal J Obstet Gynaecol. 2017;  https://doi.org/10.1111/ajo.12730.PubMedCrossRefPubMedCentralGoogle Scholar
  63. 63.
    Zhang X-L, Zhang C-W, Xu P, et al. SNP rs2470152 in CYP19 is correlated to aromatase activity in Chinese polycystic ovary syndrome patients. Mol Med Rep. 2012;5:245–9.PubMedCrossRefPubMedCentralGoogle Scholar
  64. 64.
    Carvalho LML, Ferreira CN, Candido AL, Reis FM, Sóter MO, Sales MF, Silva IFO, Nunes FFC, Gomes KB. Metformin reduces total microparticles and microparticles-expressing tissue factor in women with polycystic ovary syndrome. Arch Gynecol Obstet. 2017;296:617–21.PubMedCrossRefPubMedCentralGoogle Scholar
  65. 65.
    Api M. Could transvaginal, ultrasound-guided ovarian interstitial laser treatment replace laparoscopic ovarian drilling in women with polycystic ovary syndrome resistant to clomiphene citrate? Fertil Steril. 2009;92:2039–40.PubMedCrossRefPubMedCentralGoogle Scholar
  66. 66.
    Charalampakis V, Tahrani AA, Helmy A, Gupta JK, Singhal R. Polycystic ovary syndrome and endometrial hyperplasia: an overview of the role of bariatric surgery in female fertility. Eur J Obstet Gynecol Reprod Biol. 2016;207:220–6.PubMedCrossRefPubMedCentralGoogle Scholar
  67. 67.
    Lepine S, Jo J, Metwally M, Cheong YC. Ovarian surgery for symptom relief in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2017;11:CD009526.PubMedPubMedCentralGoogle Scholar
  68. 68.
    Pasquali R, Diamanti-Kandarakis E, Gambineri A. Management of endocrine disease: secondary polycystic ovary syndrome: theoretical and practical aspects. Eur J Endocrinol. 2016;175:R157–69.PubMedCrossRefPubMedCentralGoogle Scholar
  69. 69.
    Ozkan S, Murk W, Arici A. Endometriosis and infertility. Ann N Y Acad Sci. 2008;1127:92–100.PubMedCrossRefPubMedCentralGoogle Scholar
  70. 70.
    Prentice L, Stewart A, Mohiuddin S, Johnson NP. What is endosalpingiosis? Fertil Steril. 2012;98:942–7.PubMedCrossRefGoogle Scholar
  71. 71.
    Pavlik EJ, DePriest PD, Gallion HH, Ueland FR, Reedy MB, Kryscio RJ, van Nagell JR. Ovarian volume related to age. Gynecol Oncol. 2000;77:410–2.PubMedCrossRefGoogle Scholar
  72. 72.
    Karam K, Hajj S. Hyperthecosis syndrome. Clinical, endocrinologic and histologic findings. Acta Obstet Gynecol Scand. 1979;58:73–9.PubMedCrossRefGoogle Scholar
  73. 73.
    Sasano H, Fukunaga M, Rojas M, Silverberg SG. Hyperthecosis of the ovary. Clinicopathologic study of 19 cases with immunohistochemical analysis of steroidogenic enzymes. Int J Gynecol Pathol. 1989;8:311–20.PubMedCrossRefGoogle Scholar
  74. 74.
    Snowden JA, Harkin PJ, Thornton JG, Wells M. Morphometric assessment of ovarian stromal proliferation—a clinicopathological study. Histopathology. 1989;14:369–79.PubMedCrossRefGoogle Scholar
  75. 75.
    Rabban JT, Barnes M, Chen L-M, Powell CB, Crawford B, Zaloudek CJ. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma. Am J Surg Pathol. 2009;33:1125–36.PubMedCrossRefGoogle Scholar
  76. 76.
    Brunham RC, Gottlieb SL, Paavonen J. Pelvic inflammatory disease. N Engl J Med. 2015;372:2039–48.PubMedCrossRefPubMedCentralGoogle Scholar
  77. 77.
    Wiesenfeld HC, Hillier SL, Meyn LA, Amortegui AJ, Sweet RL. Subclinical pelvic inflammatory disease and infertility. Obstet Gynecol. 2012;120:37–43.PubMedCrossRefPubMedCentralGoogle Scholar
  78. 78.
    Furuya M, Murakami T, Sato O, Kikuchi K, Tanaka S, Shimizu M, Yoshiki T. Pseudoxanthomatous and xanthogranulomatous salpingitis of the fallopian tube: a report of four cases and a literature review. Int J Gynecol Pathol. 2002;21:56–9.PubMedCrossRefPubMedCentralGoogle Scholar
  79. 79.
    Kim SH, Kim SH, Yang DM, Kim KA. Unusual causes of tubo-ovarian abscess: CT and MR imaging findings. Radiographics. 2004;24:1575–89.PubMedCrossRefPubMedCentralGoogle Scholar
  80. 80.
    Burkman R, Schlesselman S, McCaffrey L, Gupta PK, Spence M. The relationship of genital tract actinomycetes and the development of pelvic inflammatory disease. Am J Obstet Gynecol. 1982;143:585–9.PubMedCrossRefGoogle Scholar
  81. 81.
    Evans DT. Actinomyces israelii in the female genital tract: a review. Genitourin Med. 1993;69:54–9.PubMedPubMedCentralGoogle Scholar
  82. 82.
    Boyle DP, McCluggage WG. Combined actinomycotic and pseudoactinomycotic radiate granules in the female genital tract: description of a series of cases. J Clin Pathol. 2009;62:1123–6.PubMedCrossRefPubMedCentralGoogle Scholar
  83. 83.
    Nogales-Ortiz F, Tarancón I, Nogales FF. The pathology of female genital tuberculosis. A 31-year study of 1436 cases. Obstet Gynecol. 1979;53:422–8.PubMedPubMedCentralGoogle Scholar
  84. 84.
    Chow TWP, Lim BK, Vallipuram S. The masquerades of female pelvic tuberculosis: case reports and review of literature on clinical presentations and diagnosis. J Obstet Gynaecol Res. 2002;28:203–10.PubMedCrossRefPubMedCentralGoogle Scholar
  85. 85.
    Mahdavi A, Malviya VK, Herschman BR. Peritoneal tuberculosis disguised as ovarian cancer: an emerging clinical challenge. Gynecol Oncol. 2002;84:167–70.PubMedCrossRefPubMedCentralGoogle Scholar
  86. 86.
    Bhanothu V, Theophilus JP, Rozati R. Use of endo-ovarian tissue biopsy and pelvic aspirated fluid for the diagnosis of female genital tuberculosis by conventional versus molecular methods. PLoS One. 2014;9:e98005.PubMedPubMedCentralCrossRefGoogle Scholar
  87. 87.
    Morrison JC, Givens JR, Wiser WL, Fish SA. Mumps oophoritis: a cause of premature menopause. Fertil Steril. 1975;26:655–9.PubMedCrossRefGoogle Scholar
  88. 88.
    Subietas A, Deppisch LM, Astarloa J. Cytomegalovirus oophoritis: ovarian cortical necrosis. Hum Pathol. 1977;8:285–92.PubMedCrossRefGoogle Scholar
  89. 89.
    Tutschka BG, Lauchlan SC. Endosalpingiosis. Obstet Gynecol. 1980;55:57S–60S.PubMedCrossRefGoogle Scholar
  90. 90.
    Kaneda S, Fujii S, Nosaka K, Inoue C, Tanabe Y, Matsuki T, Ogawa T. MR imaging findings of mass-forming endosalpingiosis in both ovaries: a case report. Abdom Imaging. 2015;40:471–4.PubMedCrossRefPubMedCentralGoogle Scholar
  91. 91.
    Li J, Abushahin N, Pang S, Xiang L, Chambers SK, Fadare O, Kong B, Zheng W. Tubal origin of “ovarian” low-grade serous carcinoma. Mod Pathol. 2011;24:1488–99.PubMedCrossRefGoogle Scholar
  92. 92.
    Banet N, Kurman RJ. Two types of ovarian cortical inclusion cysts. Int J Gynecol Pathol. 2015;34:3–8.PubMedCrossRefPubMedCentralGoogle Scholar
  93. 93.
    Esselen KM, Ng S-K, Hua Y, White M, Jimenez CA, Welch WR, Drapkin R, Berkowitz RS, Ng S-W. Endosalpingiosis as it relates to tubal, ovarian and serous neoplastic tissues: an immunohistochemical study of tubal and Müllerian antigens. Gynecol Oncol. 2014;132:316–21.CrossRefGoogle Scholar
  94. 94.
    Valle RF, Sciarra JJ. Endometriosis: treatment strategies. Ann N Y Acad Sci. 2003;997:229–39.PubMedCrossRefGoogle Scholar
  95. 95.
    Cohen I, Figer A, Tepper R, Shapira J, Altaras MM, Yigael D, Beyth Y. Ovarian overstimulation and cystic formation in premenopausal tamoxifen exposure: comparison between tamoxifen-treated and nontreated breast cancer patients. Gynecol Oncol. 1999;72:202–7.PubMedCrossRefPubMedCentralGoogle Scholar
  96. 96.
    Bolli P, Schädelin S, Holland-Cunz S, Zimmermann P. Ovarian torsion in children: development of a predictive score. Medicine (Baltimore). 2017;96:e8299.CrossRefGoogle Scholar
  97. 97.
    Ron-El R, Herman A, Golan A, Raziel A, Soffer Y, Caspi E. Follicle cyst formation following long-acting gonadotropin-releasing hormone analog administration. Fertil Steril. 1989;52:1063–6.PubMedCrossRefPubMedCentralGoogle Scholar
  98. 98.
    Morales C, García-Pardo L, Reymundo C, Bellido C, Sánchez-Criado JE, Gaytán F. Different patterns of structural luteolysis in the human corpus luteum of menstruation. Hum Reprod. 2000;15:2119–28.PubMedCrossRefGoogle Scholar
  99. 99.
    Beyth Y, Klein Z, Tepper R, Weinstein S, Aviram R. Hemorrhagic corpus luteum is associated with ovarian edema. J Pediatr Adolesc Gynecol. 2006;19:325–7.PubMedCrossRefPubMedCentralGoogle Scholar
  100. 100.
    Yamakami LYS, de Araujo DB, Silva CA, Baracat EC, de Carvalho JF. Severe hemorrhagic corpus luteum complicating anticoagulation in antiphospholipid syndrome. Lupus. 2011;20:523–6.PubMedCrossRefGoogle Scholar
  101. 101.
    Hatipoglu S, Hatipoglu F, Abdullayev R. Acute right lower abdominal pain in women of reproductive age: clinical clues. World J Gastroenterol. 2014;20:4043–9.PubMedPubMedCentralCrossRefGoogle Scholar
  102. 102.
    Suh DS, Han SE, Yun KY, Lee NK, Kim KH, Yoon MS. Ruptured hemorrhagic corpus luteum cyst in an undescended ovary: a rare cause of acute abdomen. J Pediatr Adolesc Gynecol. 2016;29:e21–4.PubMedCrossRefGoogle Scholar
  103. 103.
    Spinelli C, Di Giacomo M, Mucci N, Massart F. Hemorrhagic corpus luteum cysts: an unusual problem for pediatric surgeons. J Pediatr Adolesc Gynecol. 2009;22:163–7.PubMedCrossRefGoogle Scholar
  104. 104.
    Lee MS, Moon MH, Woo H, Sung CK, Jeon HW, Lee TS. Ruptured corpus luteal cyst: prediction of clinical outcomes with CT. Korean J Radiol. 2017;18:607–14.PubMedPubMedCentralCrossRefGoogle Scholar
  105. 105.
    Millet J, Much M, Gunabushanam G, Buza N, Schwartz PE, Scoutt LM. Large ovarian calcifications from an unresorbed corpus albicans. J Ultrasound Med. 2012;31:1465–8.PubMedCrossRefGoogle Scholar
  106. 106.
    Harrison BT, Berg RE, Mittal K. Massive ovarian edema associated with a broad ligament leiomyoma: a case report and review. Int J Gynecol Pathol. 2014;33:418–22.PubMedCrossRefGoogle Scholar
  107. 107.
    Harke AB, Sigamani K, Thukkaram C, Ramamurthy M, Sekar M. Massive ovarian oedema—a case report. J Clin Diagn Res. 2016;10:ED03–4.PubMedPubMedCentralGoogle Scholar
  108. 108.
    Dahmoush H, Anupindi SA, Pawel BR, Chauvin NA. Multimodality imaging findings of massive ovarian edema in children. Pediatr Radiol. 2017;47:576–83.PubMedCrossRefGoogle Scholar
  109. 109.
    Machairiotis N, Stylianaki A, Kouroutou P, et al. Massive ovarian oedema: a misleading clinical entity. Diagn Pathol. 2016;11:18.PubMedPubMedCentralCrossRefGoogle Scholar
  110. 110.
    Praveen R, Pallavi V, Rajashekar K, Usha A, Umadevi K, Bafna U. A clinical update on massive ovarian oedema - a pseudotumour? Ecancermedicalscience. 2013;7:318.PubMedPubMedCentralGoogle Scholar
  111. 111.
    Callen AL, Illangasekare T, Poder L. Massive ovarian edema, due to adjacent appendicitis. Emerg Radiol. 2017;24:215–8.PubMedCrossRefGoogle Scholar
  112. 112.
    De Cecio R, Cantile M, Fortunato N, De Chiara A, Losito NS, Franco R, Botti G. Massive edema of ovary with cytogenetic alteration of chromosome 12q13-15 in adolescent patient: a case report. J Ovarian Res. 2013;6:13.PubMedPubMedCentralCrossRefGoogle Scholar
  113. 113.
    Sasaki KJ, Miller CE. Adnexal torsion: review of the literature. J Minim Invasive Gynecol. 2014;21:196–202.PubMedCrossRefGoogle Scholar
  114. 114.
    Childress KJ, Dietrich JE. Pediatric ovarian torsion. Surg Clin North Am. 2017;97:209–21.PubMedCrossRefGoogle Scholar
  115. 115.
    Asfour V, Varma R, Menon P. Clinical risk factors for ovarian torsion. J Obstet Gynaecol. 2015;35:721–5.PubMedPubMedCentralGoogle Scholar
  116. 116.
    Spinelli C, Piscioneri J, Strambi S. Adnexal torsion in adolescents. Curr Opin Obstet Gynecol. 2015;27:320–5.PubMedCrossRefGoogle Scholar
  117. 117.
    González-Bosquet E. Ovarian vein thrombosis. Risk factors, diagnosis and treatment. Medicina (B Aires). 2009;69:347–9.Google Scholar
  118. 118.
    Kominiarek MA, Hibbard JU. Postpartum ovarian vein thrombosis: an update. Obstet Gynecol Surv. 2006;61:337–42.PubMedCrossRefGoogle Scholar
  119. 119.
    Payne JF, Robboy SJ, Haney AF. Embolic microspheres within ovarian arterial vasculature after uterine artery embolization. Obstet Gynecol. 2002;100:883–6.PubMedGoogle Scholar
  120. 120.
    Young RH, Scully RE. Fibromatosis and massive edema of the ovary, possibly related entities: a report of 14 cases of fibromatosis and 11 cases of massive edema. Int J Gynecol Pathol. 1984;3:153–78.PubMedCrossRefPubMedCentralGoogle Scholar
  121. 121.
    Lee S, Illei PB, Han JS, Epstein JI. Florid mesothelial hyperplasia of the tunica vaginalis mimicking malignant mesothelioma. Am J Surg Pathol. 2014;38:54–9.PubMedCrossRefGoogle Scholar
  122. 122.
    Clement PB, Young RH. Florid mesothelial hyperplasia associated with ovarian tumors: a potential source of error in tumor diagnosis and staging. Int J Gynecol Pathol. 1993;12:51–8.CrossRefGoogle Scholar
  123. 123.
    McCluggage WG, Young RH. Non-neoplastic granulosa cells within ovarian vascular channels: a rare potential diagnostic pitfall. J Clin Pathol. 2004;57:151–4.PubMedPubMedCentralCrossRefGoogle Scholar
  124. 124.
    Vydianath B, Ganesan R, McCluggage WG. Displaced granulosa cells in the fallopian tube mimicking small cell carcinoma. J Clin Pathol. 2008;61:1323–5.PubMedCrossRefPubMedCentralGoogle Scholar
  125. 125.
    Duncan DL, Rambally BS, Lininger RA, DiFurio MJ. Displaced granulosa cells in the fallopian tube mistaken for metastatic granulosa cell tumor. Int J Gynecol Pathol. 2013;32:35–7.PubMedCrossRefPubMedCentralGoogle Scholar
  126. 126.
    Kho RM, Abrao MS. Ovarian remnant syndrome. Curr Opin Obstet Gynecol. 2012;24:210–4.PubMedCrossRefGoogle Scholar
  127. 127.
    Magtibay PM, Magrina JF. Ovarian remnant syndrome. Clin Obstet Gynecol. 2006;49:526–34.PubMedCrossRefGoogle Scholar
  128. 128.
    Pai SA, Desai SB, Borges AM. Uteruslike masses of the ovary associated with breast cancer and raised serum CA 125. Am J Surg Pathol. 1998;22:333–7.CrossRefGoogle Scholar
  129. 129.
    Takeda A, Imoto S, Mori M, Yamada J, Nakamura H. Uterus-like mass of ovarian ligament: image diagnosis and management by laparoendoscopic single-site surgery. J Obstet Gynaecol Res. 2011;37:1895–9.PubMedCrossRefGoogle Scholar
  130. 130.
    Pueblitz-Peredo S, Luévano-Flores E, Rincón-Taracena R, Ochoa-Carrillo FJ. Uterus like mass of the ovary: endomyometriosis or congenital malformation? A case with a discussion of histogenesis. Arch Pathol Lab Med. 1985;109:361–4.Google Scholar
  131. 131.
    Shutter J. Uterus-like ovarian mass presenting near menarche. Int J Gynecol Pathol. 2005;24:382–4.PubMedCrossRefPubMedCentralGoogle Scholar
  132. 132.
    Fukunaga M. Smooth muscle metaplasia in ovarian endometriosis. Histopathology. 2000;36:348–52.PubMedCrossRefPubMedCentralGoogle Scholar
  133. 133.
    Zurkova M, Turkova M, Tichy T, Pilka R, Kolek V, Kriegova E. Sarcoidosis of female reproductive organs in a postmenopausal woman. Menopause. 2015;22:549–53.PubMedCrossRefPubMedCentralGoogle Scholar
  134. 134.
    Parveen A, Elliott H, Howells R. Sarcoidosis of the ovary. J Obstet Gynaecol (Lahore). 2004;24:465.CrossRefGoogle Scholar
  135. 135.
    Gawron I, Chmura L, Adamek D, Skotniczny K, Pityński K, Ludwin A. Laparoscopic intervention in acute Crohn’s disease involving an ovary. J Minim Invasive Gynecol. 2017;24:1040–5.PubMedCrossRefPubMedCentralGoogle Scholar
  136. 136.
    Pereira R, de Carvalho J, de Medeiros A, Silva C, Capelozzi V, Bonfá E. Ovarian necrotizing vasculitis in a patient with lupus. Lupus. 2009;18:1313–5.PubMedCrossRefPubMedCentralGoogle Scholar
  137. 137.
    Bell DA, Mondschein M, Scully RE. Giant cell arteritis of the female genital tract. A report of three cases. Am J Surg Pathol. 1986;10:696–701.PubMedCrossRefGoogle Scholar
  138. 138.
    Dincsoy HP, Rolfes DB, McGraw CA, Schubert WK. Cholesterol ester storage disease and mesenteric lipodystrophy. Am J Clin Pathol. 1984;81:263–9.PubMedCrossRefGoogle Scholar
  139. 139.
    Mount SL, Eltabbakh GH, Hardin NJ. Beta-2 microglobulin amyloidosis presenting as bilateral ovarian masses: a case report and review of the literature. Am J Surg Pathol. 2002;26:130–3.PubMedCrossRefPubMedCentralGoogle Scholar
  140. 140.
    McCluggage WG, Allen DC. Ovarian granulomas: a report of 32 cases. J Clin Pathol. 1997;50:324–7.PubMedPubMedCentralCrossRefGoogle Scholar
  141. 141.
    Clement PB, Young RH, Scully RE. Necrotic pseudoxanthomatous nodules of ovary and peritoneum in endometriosis. Am J Surg Pathol. 1988;12:390–7.CrossRefGoogle Scholar

Copyright information

© Science Press & Springer Nature Singapore Pte Ltd.  2019

Authors and Affiliations

  • David Suster
    • 1
  • Martina Z. Liu
    • 2
  • Douglas I. Lin
    • 3
    Email author
  1. 1.Department of PathologyBeth Israel Deaconess Medical CenterBostonUSA
  2. 2.Brigham and Women’s HospitalBostonUSA
  3. 3.Foundation Medicine, Inc.CambridgeUSA

Personalised recommendations